DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vqxxft/global_multiple) has announced the addition of the "Global Multiple Sclerosis Epidemiology and Patient Flow Analysis - 2012" report to their offering.
The report provides insights into Multiple Sclerosis epidemiology, Multiple Sclerosis diagnosed patients, and Multiple Sclerosis treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Multiple Sclerosis derived from epidemiological analysis, percentage of patients diagnosed with Multiple Sclerosis, and percentage of patients treated with Multiple Sclerosis therapy.
The study helps executives estimate Multiple Sclerosis market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.
The report provides estimates and forecasts of Multiple Sclerosis prevalence, Multiple Sclerosis diagnosis rate, and Multiple Sclerosis treatment rate for the period 2012-2019. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on collection and interpretation of data from registries, scientific journals and literatures, government databases and other secondary sources.
Key Features of the Report:
- Multiple Sclerosis: Disease Definition
- Multiple Sclerosis Patient Flow
- Multiple Sclerosis Prevalence
- Multiple Sclerosis Diagnosed Patients
- Multiple Sclerosis Treated Patients
For more information visit http://www.researchandmarkets.com/research/vqxxft/global_multiple